Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Maitreya Medicare IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 78  to  82 per share
Profile
Min Investment ₹82
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Maitreya Medicare Ltd is a renowned healthcare and pharmaceutical company dedicated to enhancing the well-being of individuals worldwide. With a commitment to innovation, Maitreya Medicare specializes in the development, manufacturing, and distribution of high-quality medical products, pharmaceuticals, and healthcare services. The company's core focus is on delivering cutting-edge healthcare solutions that cater to a wide spectrum of medical needs. Maitreya Medicare is driven by a vision to make healthcare more accessible, affordable, and effective, ensuring that patients receive the best possible care. Through a combination of research and development, state-of-the-art manufacturing facilities, and a global distribution network, Maitreya Medicare is at the forefront of addressing health challenges, from pharmaceuticals to medical equipment. Their mission is to improve the quality of life for patients and contribute to the advancement of healthcare on a global scale. Read More

Basic Info

Face Value 10 per share

Price 78  to  82 per share

P/E (x) 27.3

Sales( Cr.) 47

PAT( Cr.) 2

EPS 3

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Dr. Narendra Singh Tanwar Dr. Pranav Rohitbhai Thaker Mr Vimalkumar Natverlal Patel

Pre Issue Share Holding 100%

Post Issue Share Holding 86.88%

Listing Details:

Listing Price: 162.55

Listing Gain: 49.55%

Current Price: 163.8

Gain On Issue: 163.8 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Oct 27, 2023
Closing Date Nov 01, 2023
Allotment Nov 02, 2023
Refund Nov 03, 2023
Delivery of Shares Nov 03, 2023
Listing Date Nov 06, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 131,200
Retail (Max) 1 1600 131,200
S-HNI (Min) 2 3200 262,400
S-HNI (Max) 7 11200 918,400
B-HNI (Min) 8 12800 1,049,600

Objective of the Issue

1. Making investment through Equity in the subsidiary named & amp amp amp amp amp amp #039 Maitreya Hospital Private Limited& amp amp amp amp amp amp #039 for setting up a Hospital at Valsad, Gujarat. 2. Redemption of part of issued Non-Convertible Redeemable Preference Shares 3. Working Capital requirements of the company 4. General Corporate Purposes.

Issue

Category Nos Bid Bid (x)
QIB 908000 77552280 85.4x
NII 635600 472905468 744x
Retail 272400 138760560 509.4x
EMP 0 0 0x
Total 1816000 811370640 446.8x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Maitreya Medicare Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 57 49 39 48 47
Other Income 0 0 1 0 1
Total Income 57 50 40 48 47
Total Expenditure 49 46 32 42 42
Operating Profit 8 4 8 6 5
Interest 1 1 1 1 1
Depreciation 1 1 1 1 1
Exceptional Income / Expenses 0 0 -0 0 0
Profit Before Tax 6 2 6 4 3
Provision for Tax 2 0 2 1 1
Profit After Tax 4 1 4 3 2
Adjustments 0 0 0 0 0
Profit After Adjustments 4 1 4 3 2
Adjusted Earnings Per Share 8.6 2.3 8 3.9 2.8

Maitreya Medicare Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 9 10 15 30 32
Minority's Interest 1 1 1 0 1
Borrowings 8 6 6 4 4
Other Non-Current Liabilities 0 1 1 1 1
Total Current Liabilities 7 7 7 8 11
Total Liabilities 25 24 29 44 48
Fixed Assets 14 13 12 14 15
Other Non-Current Assets 1 2 4 4 5
Total Current Assets 11 9 14 25 28
Total Assets 25 24 29 44 48

Maitreya Medicare Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 2 1 2 7
Cash Flow from Operating Activities 4 0 3 -3 5
Cash Flow from Investing Activities -5 -0 0 -5 -7
Cash Flow from Financing Activities 2 -2 -2 12 4
Net Cash Inflow / Outflow 2 -2 1 4 1
Closing Cash & Cash Equivalent 2 1 2 7 8

Maitreya Medicare Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 8.56 2.29 7.98 3.86 2.76
CEPS(Rs) 10.75 4.96 11.18 6.26 4.89
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 7.79 9.5 17.68 36.67 39.43
Core EBITDA Margin(%) 12.8 6.81 18.41 12.56 10.47
EBIT Margin(%) 11.64 4.8 16.49 10.53 8.6
Pre Tax Margin(%) 10.19 3.23 15.05 8.76 6.88
PAT Margin (%) 7.5 2.3 10.8 6.22 4.01
Cash Profit Margin (%) 9.42 4.98 14.08 8.88 7.1
ROA(%) 16.79 4.57 15.93 8.16 4.08
ROE(%) 109.87 26.51 63.08 17.67 7.26
ROCE(%) 36.39 13.48 34.68 17.86 10.96
Receivable days 31.53 39.76 72.33 89.52 112.06
Inventory Days 8.8 7.58 6.88 5.37 4.69
Payable days 194.22 144.65 279.58 194.79 178.01
PER(x) 0 0 0 30.85 110.57
Price/Book(x) 0 0 0 3.25 7.75
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.2 0.23 0.37 1.78 4.49
EV/Core EBITDA(x) 1.48 3.04 1.87 13.58 38.43
Net Sales Growth(%) 0 -12.72 -20.3 21.29 -2.31
EBIT Growth(%) 0 -63.99 173.72 -22.57 -20.17
PAT Growth(%) 0 -73.22 274.24 -30.17 -36.95
EPS Growth(%) 0 -73.22 248.28 -51.66 -28.35
Debt/Equity(x) 1.03 0.78 0.4 0.19 0.16
Current Ratio(x) 1.47 1.28 1.99 2.99 2.58
Quick Ratio(x) 1.28 1.32 1.87 3.6 3.78
Interest Cover(x) 8.06 3.05 11.44 5.96 4.99
Total Debt/Mcap(x) 0 0 0 0.07 0.03

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -2% -1% 0% 0%
Operating Profit CAGR -17% 8% 0% 0%
PAT CAGR -33% 26% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -43% NA% NA% NA%
ROE Average 7% 29% 45% 45%
ROCE Average 11% 21% 23% 23%

Company Contact Information

Maitreya Medicare Ltd.

Nr Someshwara Char Rasta U. M Road

IPO Lead Manager(s)

Maitreya Medicare Ltd.

GYR Capital Advisors Pvt Ltd.

Registrar Info

Maitreya Medicare Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!